Interaction between the P1 protein of Mycoplasma pneumoniae and receptors on HEp-2 cells

M Drasbek1, G Christiansen1, K R Drasbek2

  • 1Institute of Medical Microbiology and Immunology, Bartholin Building, University of Aarhus, DK-8000 Aarhus C, Denmark.

Insights

Researchers identified specific peptides that block Mycoplasma pneumoniae (M. pneumoniae) from adhering to human respiratory cells. These M. pneumoniae inhibiting peptides target host cell receptors, offering a potential strategy against atypical pneumonia.

Area of Science:

  • Microbiology
  • Immunology
  • Cell Biology

Background:

  • Mycoplasma pneumoniae is a human pathogen causing atypical pneumonia by adhering to respiratory epithelial cells.
  • The P1 protein is crucial for M. pneumoniae attachment to host cells and is a major immunogenic target.

Purpose of the Study:

  • To investigate the adhesion properties of the P1 protein and identify specific regions or peptides involved in M. pneumoniae attachment.
  • To explore the potential of inhibiting M. pneumoniae adhesion through blocking host cell receptors.

Main Methods:

  • Production of a recombinant P1 protein fragment (rP1-II) and its evaluation in competitive-binding assays.
  • Synthesis and testing of short peptides corresponding to known epitopes and overlapping regions of rP1-II.
  • Utilizing immunofluorescence microscopy and fluorescence intensity measurements to quantify bacterial adhesion.

Main Results:

  • A recombinant P1 protein fragment (rP1-II) inhibited M. pneumoniae adhesion to HEp-2 cells.
  • While short epitope-specific peptides were ineffective, five overlapping synthetic peptides significantly reduced M. pneumoniae microcolony adhesion.
  • Inhibiting peptide 7 was found to bind directly to host cell receptors, suggesting a mechanism of blocking bacterial attachment.

Conclusions:

  • Specific synthetic peptides derived from the P1 protein can effectively inhibit M. pneumoniae adhesion to host cells.
  • The identified M. pneumoniae-inhibiting peptides function by occupying host cell receptors, thereby preventing bacterial attachment.
  • These findings highlight potential therapeutic targets for preventing or treating M. pneumoniae infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.